CURIS — Curis Lifesciences Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 40% | ||
| Return on Equity | 55.19% | ||
| Operating Margin | 20.06% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 212.6 | 237.41 | 354.19 | 355.75 | 502.59 | n/a | n/a | 24% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -13.68 | +276.13 | +171.38 | +23.34 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Curis Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral Liquid, and Sterile Ophthalmic Ointments. The Company manufactures activities on loan license, Contract Manufacturing and Direct Export basis/Own Brand Marketing basis. Its products include general pharmaceutical tablets, general pharmaceutical capsules, general oral liquid, general external preparation, and sterile ophthalmic ointment. Its pharmaceutical tablets are solid dosage form of medication used for delivering active pharmaceutical ingredients. Its sterile ophthalmic ointment is a type of medication formulated for use in the eyes. Its oral liquid is versatile form of medication to be taken by mouth.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- March 31st, 2025
- Incorporated
- March 22nd, 2016
- Public Since
- November 14th, 2025
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Address
- Industrial Estate, AHMEDABAD, 382110
- Web
- https://curisls.com/
- Phone
- Auditors
- B. T. VORA & CO
Similar to CURIS
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 19:09 UTC, shares in Curis Lifesciences are trading at IN₹137.50. This share price information is delayed by 15 minutes.
Shares in Curis Lifesciences last closed at IN₹137.50 and the price had moved by over the past 365 days. In terms of relative price strength the Curis Lifesciences share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreCuris Lifesciences does not currently pay a dividend.
Curis Lifesciences does not currently pay a dividend.
Curis Lifesciences does not currently pay a dividend.
To buy shares in Curis Lifesciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹137.50, shares in Curis Lifesciences had a market capitalisation of .
Here are the trading details for Curis Lifesciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: CURIS
Based on an overall assessment of its quality, value and momentum Curis Lifesciences is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Curis Lifesciences. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹137.50, shares in Curis Lifesciences were trading -0.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Curis Lifesciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹137.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Curis Lifesciences' directors